Nesfatin-1 as a potential marker for functional hypothalamic amenorrhea.
Anna SzeligaAgnieszka PodfigurnaBłażej MęczekalskiPublished in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2022)
This is the first known study to examine nesfatin-1 concentration in the context of clinical FHA. Patients with FHA were found to have decreased serum nesfatin-1 concentrations. This finding may prove instrumental in our future approach managing patients with FHA.
Keyphrases